The strength of our study was the meticulous exclusion of any condition associated with elevated levels of CK18 or M30 antigen in the blood [33,39,40,41,42,43,44,45] and the recruitment of patients with mostly sarcomeric hypertrophic cardiomyopathy. This evidence concerns the gene KRT18 and hypertrophic cardiomyopathy.